Scarica l'app Stockscreener
32.30
0.59%
0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
Lupin Concedes To Harmony On Generic Wakix With 2030 Launch Agreement - insights.citeline.com
Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment - MyChesCo
Rhumbline Advisers Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) Investment Analysis - news.stocktradersdaily.com
Equities Analysts Set Expectations for HRMY FY2026 Earnings - Defense World
Harmony Biosciences Presents Preclinical Data Demonstrating Sign - GuruFocus
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 By Investing.com - Investing.com South Africa
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 - Investing.com Canada
HRMY: Harmony Biosciences Shows Promising Preclinical Data for BP1.15205 | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 - StreetInsider
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - MSN
Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by California State Teachers Retirement System - Defense World
Transcript : Harmony Biosciences Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener
Harmony Biosciences settles patent litigation with Lupin By Investing.com - Investing.com South Africa
Harmony Biosciences, Lupin reach agreement on Wakix generic launch - MSN
Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - BioSpace
Harmony Biosciences (HRMY) Settles Patent Dispute with Lupin | HRMY Stock News - GuruFocus
Harmony Biosciences settles patent litigation with Lupin - Investing.com Australia
Harmony Biosciences Strengthens Patent Position With Favorable Settlement In ANDA Litigation - MarketScreener
Harmony Biosciences Strengthens Patent Position With Favorable S - GuruFocus
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance
Top 5 US Stocks To Buy In June 2025 - Investing.com
Harmony Biosciences (NASDAQ:HRMY) Now Covered by Analysts at Oppenheimer - Defense World
Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) | HRMY Stock News - GuruFocus
(HRMY) On The My Stocks Page - news.stocktradersdaily.com
Oppenheimer assumes Outperform rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria
Oppenheimer assumes Outperform rating on Harmony Biosciences stock - Investing.com
Harmony Biosciences (HRMY) Receives Outperform Rating from Oppen - GuruFocus
Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform - StreetInsider
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) - GuruFocus
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World
The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World
Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 - Investing.com
Harmony Biosciences (HRMY) Sees Price Target Increase Following Positive Q1 Results | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 By Investing.com - Investing.com India
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):